Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bismuth Subsalicylate for Antimicrobial Use in Diarrhea
NCT02047162Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- May 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in diarrhea comparing Bismuth subsalicylate with Placebo (2 arms). Primary endpoint: Use of antimicrobial medications at 5 days. Started May 2014; status: completed.
02
Drugs
bismuth subsalicylate
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT02047162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02047162.